• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

M&G Positive Impact GBP L Acc (Restricted Fund)

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider M&G Securities Ltd
Fund Summary The Fund has two aims: To provide a higher total return (the combination of capital growth and income), net of the Ongoing Charges Figure, than the MSCI ACWI Index over any five-year period; and To invest in companies that aim to have a positive societal impact through addressing the world™s major social and environmental challenges.
SEDOL code BG886D2
ISIN GB00BG886D26
Fund code MGPLA
Managers John Olsen, Michael Oliveros
Manager Tenure 2 years
Morningstar Category Global Large-Cap Growth Equity
IMA Sector Global
Fund Size £90 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.6%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.2761
Buy Price £1.2761
Price Change -0.7543%
Price Date 8th July 2020
Yield Currently unavailable
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 14th October 2019
Fund Status OPEN
John William Olsen joined M&G in April 2014, and was appointed FM of the Eastspring Pan European Fund, M&G Global Select Fund and M&G Pan European Select Fund in July 2014. He was later appointed deputy manager of the M&G Pan European Select Smaller Companies Fund in July 2016. He joined Danske Capital in 1998 as a FM in domestic Danish equities, and in 2000 also became a global sector analyst focusing on technology and telecommunications. From 2002 he managed non-domestic equity. He has a BA in business economics and a MSc in finance and accounting from Copenhagen Business School.

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2019
Fund Performance +8.60%
Benchmark Performance
(Global Large-Cap Growth Equity)
+12.78%
Time Period Cumulative Benchmark Performance
(Global Large-Cap Growth Equity)
Fund Compared to Benchmark
1 day -0.75% +10.93% -11.68%
1 week 0.66% +3.56% -2.90%
1 month -0.64% +21.64% -22.28%
3 months 18.05% +9.41% +8.64%
6 months 3.95% +12.69% -8.74%
1 year 6.14% +18.77% -12.64%
3 years Currently unavailable Currently unavailable Currently unavailable
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 4.32% +1.92% +2.40%
Since inception 16.12% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Orsted A/S DNK 5.35%
Novo Nordisk A/S B DNK 4.97%
Ansys Inc USA 4.51%
AIA Group Ltd HKG 4.04%
Alk-Abello A/S B DNK 4.00%
UnitedHealth Group Inc USA 3.63%
Becton, Dickinson and Co USA 3.59%
Fresenius Medical Care AG & Co. KGaA DEU 3.55%
Thermo Fisher Scientific Inc USA 3.53%
SolarEdge Technologies Inc USA 3.46%
Dividend Date Per share amount Reinvestment Price
1st April 2020 0.0098 £1.0306
1st April 2019 0.0015 £1.0658